PROCEPT BioRobotics (PRCT) Total Non-Current Liabilities (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Total Non-Current Liabilities for 7 consecutive years, with $139.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Non-Current Liabilities rose 7.22% year-over-year to $139.3 million; the TTM figure through Mar 2026 stood at $139.3 million (up 7.22% YoY), while the FY2025 annual figure was $142.1 million, up 8.06% from the prior year.
• Total Non-Current Liabilities retreated to $139.3 million in Q1 2026 per PRCT's latest filing, from $142.1 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $142.1 million in Q4 2025 and bottomed at $66.6 million in Q1 2022.
• Historically, Total Non-Current Liabilities has averaged $117.3 million across 5 years, with a median of $122.1 million in 2024.
• Annual changes were most pronounced in 2023 — Total Non-Current Liabilities jumped 64.38% — and 2025, when it slipped 1.33%.
• PROCEPT BioRobotics' Total Non-Current Liabilities stood at $112.3 million in 2022, then climbed by 9.97% to $123.4 million in 2023, then advanced by 6.5% to $131.5 million in 2024, then advanced by 8.06% to $142.1 million in 2025, then retreated by 1.96% to $139.3 million in 2026.
• Business Quant data shows PRCT's Total Non-Current Liabilities at $139.3 million in Q1 2026, $142.1 million in Q4 2025, and $130.7 million in Q3 2025.